Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220828 · ClinicalTrials.gov registry record · NA
Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access
A NA study of Stress, Emotional, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT03220828: Completed NA study of Stress, Emotional, sponsored by Stanford University.
NCT03220828 is a NA study of Stress, Emotional that has completed, run by Stanford University. The registered enrollment target is 220 participants, below the 350-participant average among 7 other Stress, Emotional trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03220828, a NA study of Stress, Emotional, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Preprocedural, preoperative, and prevascular access anxiety in pediatric patients has been previously shown to increase the likelihood of family stressors, postoperative pain, agitation, sleep disturbances, and negative behavioral changes. The purpose of this study is to determine if a non-invasive distracting devices (Virtual Reality headset) is more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety before vascular access among hospitalized children undergoing vascular access prior to anesthesia, procedures, surgery, blood draws, port access, or peripheral IV placement. The anticipated primary outcome will be reduction of child's anxiety during and after vascular access.
Primary Outcome
Peak Pain Score minus Baseline Pain Score(0-10)
Conditions Studied
Interventions
- BEHAVIORAL Technology Based Distractions
Study Locations (1)
California
- Lucile Packard Children's Hospital at Stanford - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-03-31 |
| Phase | NA |
What the finished NCT03220828 record still lists
NCT03220828 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 350-participant average among 7 other Stress, Emotional trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Stress, Emotional appearing as the primary indexed condition, and to 1 intervention - of which Technology Based Distractions is the first listed.
NCT03220828 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03220828 about?
NCT03220828 is a clinical study titled "Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access". Preprocedural, preoperative, and prevascular access anxiety in pediatric patients has been previously shown to increase the likelihood of family stressors, postoperative pain, agitation, sleep disturbances, and negative behavioral changes. The purpose of this study is to determine if a non-invasive ...
What is the current status of trial NCT03220828?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2017-08-01. Estimated completion is 2019-03-31.
What conditions does trial NCT03220828 study?
This clinical trial studies the following conditions: Stress, Emotional.
What interventions are being tested in trial NCT03220828?
The interventions under investigation include: Technology Based Distractions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03220828?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03220828 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress, Emotional
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Human Stress Response in a Simulated ED Setting
ACTIVE NOT RECRUITING · NA
-
Biology, Identity & Opportunity Study
ACTIVE NOT RECRUITING · NA
-
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
ACTIVE NOT RECRUITING · NA
-
Healthy Motivations for Moms-to-be Study
COMPLETED · NA
-
Engaging Women With the Gabby System to Deliver Multiple Health-Related Behavioral Changes: A Feasibility Study
COMPLETED · NA
-
Sleep Hygiene Intervention on Undergraduate Students' Sleep and Stress
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI